Conference Coverage: SABCS 2024
Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment
December 17, 2024
FACULTY CHAIR
Adam Brufsky, MD, PhD
University of Pittsburgh School of Medicine, PA, USA
Faculty Members
Mark Pegram, MD
Stanford University School of Medicine, Stanford, CA, USA
Joyce A. O’Shaughnessy, MD
Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX, USA
William Sikov, MD, FACP, FNCBC
Women & Infants Hospital of Rhode Island, Providence, RI, USA
Sara Tolaney, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, USA
Javier Cortés, MD, PhD
International Breast Cancer Center, Barcelona, Spain
Nadia Harbeck, MD, PhD
Ludwig-Maximilian University of Munich, Germany
REPORT TOPICS INCLUDE
- New and Emerging Treatments in HER2+ Early and Metastatic BC
- New and Emerging Approaches in HR+, HER2– Early BC
- New and Emerging Approaches in HR+, HER2– Metastatic BC
- Advances in Early and Metastatic Triple-Negative Breast Cancer (TNBC)
